Evidence map›Paper›PMID 41593426›Full record

ArticleJournal of cancer survivorship : research and practice2026

Survivorship care guidance in a diverse cancer survivor population: Cancer Registry for Understanding and Improving Survivorship Experiences (CRUISE) Study.

Scarlett Lin Gomez, Salma Shariff-Marco, Alyssa Cortella, Debora Oh, Pari Srivastava, Vlad Honcharov, Christine Duffy, Zinnia Loya, Michelle Wadhwa, Kathie Lau and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of cancer survivorship : research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Scarlett Lin GomezHelen Diller Family Comprehensive Cancer Center, University of California, San Francisco, USA. Scarlett.gomez@ucsf.edu.
Salma Shariff-MarcoHelen Diller Family Comprehensive Cancer Center, University of California, San Francisco, USA.
Alyssa CortellaDepartment of Epidemiology & Biostatistics, University of California, 550 16th St. 2nd Floor, San Francisco, CA, 94158, USA.
Debora OhDepartment of Epidemiology & Biostatistics, University of California, 550 16th St. 2nd Floor, San Francisco, CA, 94158, USA.
Pari SrivastavaUniversity of California, San Diego, USA.
Vlad HoncharovDivision of General Internal Medicine, University of California, San Francisco, USA.
Christine DuffyDepartment of Epidemiology & Biostatistics, University of California, 550 16th St. 2nd Floor, San Francisco, CA, 94158, USA.
Zinnia LoyaDepartment of Epidemiology & Biostatistics, University of California, 550 16th St. 2nd Floor, San Francisco, CA, 94158, USA.
Michelle WadhwaDepartment of Epidemiology & Biostatistics, University of California, 550 16th St. 2nd Floor, San Francisco, CA, 94158, USA.
Kathie LauDepartment of Epidemiology & Biostatistics, University of California, 550 16th St. 2nd Floor, San Francisco, CA, 94158, USA.
Kristan OlazoDivision of General Internal Medicine, University of California, San Francisco, USA.
Niharika DixitZuckerberg San Francisco General Hospital,, San Francisco, USA.
Urmimala SarkarDivision of General Internal Medicine, University of California, San Francisco, USA.

Funding

Cancer Registry for Understanding and Improving Survivorship Experiences (CRUISE)R01CA241128 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GOMEZ, SCARLETT L, SARKAR, URMIMALA · 2019 to 2023
$3.2M
NCI NIH HHS R01CA241128
6 · The paper itself

Abstract

purposeUsing a population-based approach, the CRUISE Study is designed to understand disparities in receipt of survivorship care guidance among medically under-resourced cancer survivors.

methodsEligible participants identified from the Greater Bay Area Cancer Registry were those newly diagnosed with first primary stage I-III breast or colorectal cancer. Patients from medically under-resourced communities, defined on the basis of ethnic minority group, underinsurance, and/or living in a low socioeconomic status (SES) neighborhood, were oversampled. Using data derived from patient surveys, cancer registry, and geospatial linkage, patient, facility, and neighborhood attributes were assessed for associations with receipt of survivorship care guidance using univariate and multivariable log binomial regression models.

resultsOf 867 participants (332 breast cancer, 474 colorectal cancer), 62% identified with a non-White racial/ethnic group, 20.6% resided in a low SES neighborhood, and 9.3% were uninsured or publicly insured. Overall, 72.2% received survivorship care guidance. In a multivariable model, female breast cancer survivors relative to male colorectal cancer survivors (RR: 0.89, 95% CI: 0.81-0.97), and unemployed (RR: 0.80, 95% CI: 0.68-0.94) and retired (RR: 0.85, 95% CI: 0.77-0.95) versus employed people remained significantly less likely to receive guidance. Those who strongly agreed as well as those who disagreed that they could get medical care without financial setbacks were also significantly more likely to have received guidance than those who neither agreed nor disagreed (RR: 1.28, 95% CI: 1.09-1.51 for strongly agreed; RR: 1.22, 95% CI: 1.01-1.46 for disagreed).

conclusionsThe CRUISE Study demonstrated feasibility in accruing a population-based sample of cancer survivors with over-representation of medically under-resourced patients. IMPLICATIONS FOR CANCER SURVIVORS: A high proportion received survivorship guidance, including survivorship care plans or post-treatment guidance, but some variations were found across some patient characteristics.

Indexed as

DisparitiesRace and ethnicitySocioeconomic statusSurvivorship care plans

Identifiers

PMID41593426

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.